Mullerian inhibiting substance inhibits breast cancer cell growth through an NFκB-mediated pathway

Dorry L. Segev(Harvard University Press), Shyamala Maheswaran(Massachusetts General Hospital), Thanh U. Ha(Harvard University), D. MacLaughlin(Harvard University Press), Patricia K. Donahoe(Harvard University Press), Mira Jung(Georgetown University), Paul Harkin(Cancer Research UK), Trinh T. Tran(Harvard University), Mary Kenneally(Harvard University)
Research Portal (Queen's University Belfast)
September 15, 2000
Cited by 0

Related Papers

Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
|Cell|2010|2.8k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
|Proceedings of the National Academy of Sciences|2010|1.6k